mj80

mj80 Ruben Amorim impressed with Arsenal’s corners after first defeat as Man Utd bossNone

T'puram: The state is witnessing a troubling rise in child kidnapping cases, with 405 incidents reported involving children under 18 from Jan 2021 to Sept 2024. The statistics reveal a concerning trend: 101 cases in 2021, 114 in 2022 and 124 in 2023. However, in the face of this challenge, the law enforcement agencies are stepping up their efforts to ensure the safety of children. Despite the increase in reported kidnappings, the police made significant strides in resolving these cases. IPL 2025 mega auction IPL Auction 2025: Who got whom IPL 2025 Auction: Updated Full Team Squads In 2021, they successfully solved 98 cases, with numbers rising to 111 in 2022 and 119 in 2023. In 2024, an impressive 63 out of 66 reported cases have already been resolved, reflecting a commitment to swift action and community safety. Local law enforcement agencies adopted a proactive approach to address the rising trend of kidnappings. When incidents are reported, police take immediate action, coordinating efforts across districts and utilising technology to disseminate information quickly. Alerts are issued at transportation hubs and through social media, ensuring that the community is informed and vigilant. Recent success stories highlight the effectiveness of these efforts. Children such as Tasmith Thamsum, Abigail Sara and Niya Mehrin were located thanks to prompt police intervention, leading to heartfelt gratitude from their families. These cases serve as a reminder of the importance of community awareness and cooperation in ensuring child safety. A senior police official pointed out the vital role of media in these efforts, stating, "The ever-vigilant media influence is a key factor in police being forced to relentlessly pursue such cases. The case of Abigail Sara is the best example of how media vigilance can help law enforcement agencies fulfil their duties." The community is also becoming increasingly engaged in addressing the issue. Increased awareness campaigns and educational programmes are being implemented to inform parents and children about safety measures and the importance of reporting suspicious activity.After a week of rumours and misinformation, Kelowna RCMP have set the record straight about a video that's recently gone viral. A video has been circulating various social media sites showing a woman yelling in a local convenience store and along with her dog, who aggressively barked at the store attendants. Someone in the store who was "trying to buy a sandwich" filmed the whole incident. According to RCMP, the incident took place over a year ago, on Sept. 19, 2023 at the Canco gas station in the 1100-block of Ethel Street. "Officers attended where it was determined an unknown female attacked two store employees and attempted to coerce her dog into biting them," said Kelowna RCMP in a press release. The incident was captured on cell phone video which was provided to police at the time. The next day, the woman was found and arrested for assault. She was released with an undertaking scheduled for court at a later date. Just over a month later, RCMP concluded their investigation at the request of the victims affected because the woman had never returned to the store and one of the victims no longer lives in the province. “For reasons unknown, this video only recently surfaced on social media over a year after the incident was reported and investigated by police,” RCMP media relations officer Cpl. Michael Gauthier. “In this particular case, when the victims of the offence(s) are no longer interested in pursuing charges, we are obligated to cancel the Undertaking and conclude the matter as is.”

In a welcome move, ( ) stock saw its rise from 68 to 75 on Friday. This proprietary rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database. Over 100 years of market history reveals that the best stocks tend to have an 80 or higher RS Rating as they launch their biggest price moves. See if CF Industries Holdings stock can continue to rebound and clear that threshold. Is CF Industries Holdings Stock A Buy? CF Industries Holdings stock broke out earlier, but has fallen back below the prior 90.86 entry from a . If a stock you're watching breaks past a buy point then falls 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new base and breakout. Also keep in mind that the latest consolidation is a later-stage base, and those involve more risk. In terms of top and bottom line numbers, the company has posted rising EPS growth over the last three quarters. Top line growth has also risen over the same time frame. CF Industries Holdings stock holds the No. 2 rank among its peers in the Chemicals-Agriculture industry group. ( ) is the No. 1-ranked stock within the group.

Türkiye's technology startup ecosystem has shown significant growth recently and has attracted $4.7 billion in investments in the last four years, according to vice president of Türkiye's Investment Office, Bekir Polat, on Saturday. Polat evaluated the technology ecosystem in an interview with Anadolu Agency (AA) during a major startup conference held in the Finnish capital Helsinki, Slush 2024. "In the 2011-2021 period, our startups received approximately $810 million in investments. However, when we look at the last four years, especially if we take into account the first nine months of 2024, when an investment of $700 million was received, an investment of $4.7 billion came to Türkiye," Polat remarked. He noted that as the Presidency Investment Office, they aim to present Türkiye's technology startup ecosystem in different environments, such as Slush while also recalling the participation at the recent Web Summit in Lisbon. "We want to somehow explain both Türkiye's developed ecosystem with all its players and the public incentives given. These events have another importance. When we look at the world recently, the investments coming from technology initiatives have a serious meaning in terms of employment, growth and other inputs in the economy," he explained. "We also hope that our Turkish entrepreneurs will get more of this share," he added. Furthermore, he pointed out at some key opportunities and value propositions that investors need to bear in mind such as the strong growth of the Turkish economy in the last two decades, a young and talented workforce, a strong entrepreneurial culture as well as unique location. He also noted that Türkiye has seven unicorns (the term used for startups exceeding $1 billion in value), while adding "that there are many unicorn candidates in the country." "We are working tirelessly to cultivate more 'Turcorns,'" Polat added, referring to a term used for Turkish unicorns. He also recalled the recent investment strategy for the period between 2024 and 2028, emphasizing that sustainability, green transformation and digital transformation, which have become very important recently, are at the center of this strategy. Polat, who stated that while meeting with international investors, they saw many young talents from Türkiye working in many companies and rising to higher levels, stated that young people believing in Türkiye's potential will take the country to the next level. "Our country, with its 85 million population in its region, an average age of 33 and a half, an educated, young, qualified and sophisticated production power, is actually, as investors sometimes say, 'the biggest economic power and regional power between Germany and China.' And of course, this is not enough. We have bigger goals. Hopefully, as a country, we will be working together to rise to higher levels in many areas," he concluded.CHASKA — Tori Oehrlein finished with 22 points and 17 rebounds as Class 2A’s third-ranked Crosby-Ironton Rangers opened with a 63-52 victory over No. 8-ranked Jordan Saturday, Nov. 23. C-I’s Regan Jueneman finished with 19 points and Sammie Hachey scored 12. ADVERTISEMENT HAWLEY — The Staples-Motley Cardinals fell to the Hawley Nuggets 60-43 in their inaugural game in the Heart O’ Lakes Conference Saturday, Nov. 23. S-M moves to 1-1 overall and will face Pelican Rapids 6:30 p.m. Tuesday, Nov. 26, in Pelican Rapids.

Travis Hunter and Ashton Jeanty give this year's Heisman Trophy ceremony a different vibe

Global stocks mostly rose Tuesday, with US and German indices posting records, as markets weighed Chinese stimulus hopes, political tensions in France and the US interest-rate outlook. Germany's blue-chip DAX stock index jumped above 20,000 points for the first time and Paris rebounded even as France braced for new political turmoil. In New York, both the S&P 500 and Nasdaq narrowly rose to finish at records, while the Dow pulled back. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.NoneLYNN — The Lynn Classical vs. Lynn English powderpuff game, an annual tradition in which senior girls compete in a two-hand-touch football game, delivered the theatrics on Sunday – and then some. The Rams escaped the Bulldogs, 20-19, in a thriller that came down to the very last play. With English trailing, 20-13, in the final minute, the girls in maroon nearly pulled it off. Jade Quero rushed for a 12-yard touchdown as time expired, but the extra-point attempt to tie was no good. The Classical faithful bounced up and down on the bleachers in celebration, and that was all she wrote on the Manning Field scoreboard. But truth be told, this one was back-and-forth from the beginning. Classical came out hot on its first drive, led by the explosive ground game of Keisha Perez. From there, Maegan Baker broke free and rushed for a touchdown down the right sideline. “This is something that I’ve thought about since freshman year,” Baker said. “It’s something I really look forward to and I’m really proud of myself and the rest of the team. I think they did really well.” Baker, who has committed to Marymount University (Virginia) to study and play flag football, said powderpuff is “a really good way to involve everyone. “Everyone I play with now, I wouldn’t have expected to be close with,” she said. “It’s a really good way to include everybody and get them out on the field.” English answered Classical’s early score with a touchdown of its own, courtesy of Yankarla Matias in the first quarter. “I had a lot of fun,” said Matias, who found the endzone twice on Sunday. “I was really excited, nervous, and I really wanted to make it down there (the endzone).” But Classical recaptured its lead in the second quarter as Perez spotted Nevaeh Eth for a touchdown through the air. The Rams led, 13-7, at halftime. Matias found the endzone again in the third quarter. This time, a 40-plus yard rush to tie the game, 13-13. But Baker did her thing again in the fourth, just barely squeezing into the endzone for a 7-yard rush. The point-after attempt was good (20-13). “I think we just needed to stay positive,” Baker said. “Our team has worked together a lot and we backed each other up.” Sunday made it three consecutive wins for the Rams. They won last year’s matchup, 34-18.

BERWYN, Pa.--(BUSINESS WIRE)--Nov 21, 2024-- Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an extension of its cooperative research and development agreement with the National Center for Advancing Translational Sciences (NCATS), an institute/center of the National Institutes of Health (NIH), U.S. Department of Health and Human Services. This collaboration is for the continued development of Virpax’s product candidate, NES100, an intranasal peptide, for the management of acute and chronic non-cancer pain. NES100 is an enkephalin drug product based on a type of nanotechnology delivery approach. Enkephalin is a naturally occurring (endogenous) peptide that is not easily administered in its original form. We believe that the nanotechnology may enable and enhance the delivery of this metabolically labile peptide drug into the brain. NES100 is the first investigational product formulation delivered via the nasal route with the potential to enhance enkephalin transport to the brain. NES100 uses a preassembled device and cartridge to propel the enkephalin formulation through the nose to the brain by flowing along the olfactory nerve pathway. The Molecular Envelope Technology (MET) is designed to protect and help carry the drug to the brain with the goal of promptly suppressing pain by binding to the delta opioid receptors. NES100 has demonstrated analgesic potential in animal models without the development of opioid tolerance, withdrawal, respiratory depression, euphoria, or addiction associated with use of opioids. Jatinder Dhaliwal, Chief Executive Officer of Virpax, commented, "We are excited that this collaboration has been extended with NCATS and the NIH Helping to End Addiction Long-term (HEAL) initiative as we believe that it may help Virpax develop an effective and safe alternative to conventional opioids used by patients to manage acute and chronic pain. We believe that the NIH/NCATS collaborative agreement will enable our team to maintain momentum in both our pre-clinical and clinical development strategies." About Virpax Pharmaceuticals Virpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval for two prescription drug candidates that employ two different patented drug delivery platforms. ProbudurTM is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain and EnveltaTM is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. Virpax is also using its intranasal Molecular Envelope Technology (MET) to develop one other prescription product candidate, NobrXiolTM, which is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy. Virpax has competitive cooperative research and development agreements (CRADAs) for two of its prescription drug candidates, one with the National Institutes of Health (NIH) and one with the Department of Defense (DOD). Virpax is also seeking partners for two nonprescription product candidates: AnQlar, which is being developed to inhibit viral replication caused by influenza or SARS-CoV-2, and EpoladermTM, which is a topical diclofenac spray film formulation being developed to manage pain associated with osteoarthritis. For more information, please visit https://www.virpaxpharma.com .and follow us on Twitter, LinkedIn and YouTube. Forward-Looking Statements This press release contains certain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended, including those described below. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors, including the additional capital which will be necessary to complete studies and clinical trials that the Company plans to initiate and other factors listed under “Risk Factors” in the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that the Company has filed with the U.S. Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. View source version on businesswire.com : https://www.businesswire.com/news/home/20241121242163/en/ CONTACT: Investor Contact: info@virpaxpharma.com KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL MEDICAL SUPPLIES SOURCE: Virpax Pharmaceuticals, Inc. Copyright Business Wire 2024. PUB: 11/21/2024 04:05 PM/DISC: 11/21/2024 04:06 PM http://www.businesswire.com/news/home/20241121242163/enHow Big Tech’s XR Push Could Redefine Both Payments and AI

24X National Exchange Plans to be the First Exchange to Offer U.S. Equities Trading 23 Hours-Per-Day on Weekdays STAMFORD, Conn. , Nov. 27, 2024 /PRNewswire/ -- 24 Exchange announced today that it has received approval from the U.S. Securities and Exchange Commission to operate 24X National Exchange as the first national securities exchange in the U.S. that allows trading of U.S. securities 23 hours each workday. The extended hour trading is subject to Equity Data Plans making changes that would facilitate overnight trading hours and 24X National Exchange making an additional rule filing with the SEC confirming the changes and the Exchange's ability to comply with the Securities Exchange Act. 24X National Exchange will be subject to the SEC's ongoing regulatory oversight and full range of investor protections. The new Exchange will enable retail and institutional customers anywhere in the world to trade in U.S. equities via broker-dealers who are approved members of 24X National Exchange. 24X National Exchange will be launched in two stages. A first stage will open in the second half of 2025, with the Exchange operating from 4:00AM ET to 7:00PM ET on weekdays. The second stage, which will launch once the conditions noted above are met, will offer trading in U.S. equities from 8:00PM ET on Sunday through 7:00PM ET on Friday . A one-hour operational pause will occur during each trading day to accommodate routine software upgrades and functionality testing. 24 Exchange CEO and Founder Dmitri Galinov said: "The SEC's approval of our new exchange is a thrilling development that the 24X Team has been working toward for many years. Traders are most at-risk when the market is closed in their geographic location. 24X National Exchange will seek to alleviate this problem by facilitating around-the-clock U.S. equities trading for broker-dealers and their institutional and retail customers." As the first national securities exchange approved by the SEC to operate 23 hours each weekday, subject to the conditions noted above, 24X National Exchange will initially focus on capturing the expanding demand in the APAC region for overnight liquidity in U.S. equities. The 24X National Exchange will run on a proven, state-of-the-art technology platform provided by MEMX Technologies. The new Exchange's executive team will place a high priority on enhancing client experience through continuous technology innovations and improvements. "With this historic SEC approval in place, we will build and operate a customer-driven Exchange that can rapidly align with market demands and adapt quickly to client feedback," Galinov added. "We look forward to bringing a superior trading experience to global customers. 24X National Exchange will deliver the cost efficiency, speed, resilience, and adaptability that the company's financial institutional customers have long come to expect." 24X National Exchange will close on U.S. market holidays, similar to the schedules maintained by the NYSE and Nasdaq. 24 Exchange through 24X Bermuda Limited, an affiliate of 24X National Exchange, will continue to offer FX NDFs, Swaps and Spot trading to institutional clients. Since its launch in 2019, 24 Exchange's multi-asset offering through a single trading interface has enabled clients to access increased liquidity at lower cost. About 24 Exchange 24 Exchange allows market participants to seamlessly exchange their exposures at the lowest possible cost. 24 Exchange's mission is to enable members to initiate the most cost-effective trades across a growing range of asset classes, 24 hours a day. 24 Exchange lowers the cost of exchanging assets in the global markets while delivering creative and unique workflows catered to each asset class. More information is available at https://24exchange.com/ . Media Contact: Eric Andrus , KARV 24Xmedia@karv.global Phone: +1 (212) 333-0275 View original content: https://www.prnewswire.com/news-releases/24-exchange-receives-sec-approval-of-its-new-national-securities-exchange-24x-national-exchange-302317878.html SOURCE 24 ExchangeParliament to meet on Tuesday, Wednesday

Eastern states were considered backward earlier, I view them as India’s growth engine: PM ModiAida Bravo And BRAVO STUDIO® Nominated For Creative & Visual Arts Awards 2024ANALYSIS: Legal threats close in on Israel’s Netanyahu

NEW YORK – The U.S. Securities and Exchange Commission has given Elon Musk until Monday to respond to an offer to resolve a probe into the billionaire's $44-billion takeover of Twitter in 2022, a source familiar with the matter told Reuters. More: Elon Musk's skyrocketing net worth: He's the first person with over $400 billion The development, which signals the investigation may be nearing a conclusion, is the latest salvo in a year-long public feud between the top U.S. markets regulator and the world's richest man. Musk on Thursday posted on X a copy of a letter sent by his lawyer to SEC Chair Gary Gensler saying the agency had given Musk 48 hours to agree to pay a penalty to settle the probe or face civil charges, and demanding to know whether Gensler was personally behind the development. The SEC has been investigating whether Musk broke securities laws in 2022 when he bought stock in Twitter, which Musk subsequently renamed X, as well as statements and filings he made in relation to the deal, previous disclosures show. Holiday deals: Shop this season’s top products and sales curated by our editors. More: Elon Musk takes center stage as Trump's influencer and enforcer on Capitol Hill and beyond According to the source, the agency has been probing Musk's SEC filing disclosing his Twitter share purchases, which was at least 10 days late, and whether he intended to benefit from thatdelay, which some academics have estimated saved Musk over $140 million. As part of the probe, the agency had asked a federal court to compel Musk to testify after the billionaire failed to show up to agreed depositions. On Tuesday, the SEC sent Musk a settlement offer seeking a response in 48 hours, but extended the deadline to Monday after a request for more time, the source said, speaking on the condition of anonymity to discuss confidential enforcement matters. A spokesperson with the SEC's public affairs office declined to comment. Musk's lawyer did not respond immediately to calls for comment. SEC aiming for settlements The SEC commonly tries to resolve probes through settlements rather than suing a defendant, but the initial 48-hour deadline was unusually tight, legal experts told Reuters. If Musk failsto respond, the SEC will likely proceed through a "Wells" notification process, a formal step in which the SEC outlines potential charges and allows Musk to respond, the source said. The Thursday letter Musk shared on X, which was signed by his attorney Alex Spiro, said the SEC has also reopened an investigation into Musk's brain-chip startup Neuralink. Neuralink did not respond to requests for comment. The nature of that inquiry is not clear, but U.S. lawmakers and animal-rights advocates have pressed the SEC to scrutinize comments Musk has made about the safety of Neuralink's implants. The SEC first sued Musk in 2018 during President-elect Donald Trump's first term, accusing him of breaking the law when he posted on social media that he had "funding secured" to take hiselectric carmaker Tesla private when the SEC found he had not. Despite ultimately settling and agreeing to an unusual arrangement requiring some of his posts to be vetted by an attorney, Musk subsequently disputed the SEC's findings in thatcase and has over the years accused the agency of harassment -claims Spiro reiterated in his Thursday letter. "We demand to know who directed these actions - whether it was you or the White House," Spiro wrote to Gensler. A major backer of Trump, Musk in the new administration will co-lead the new Department of Government Efficiency tasked with cutting government costs, potentially giving him some power over the SEC's workings.

Classical escapes English in powderpuff thriller